The company is focused in the areas of Congestive Heart Failure (CHF) and Coronary Artery Disease (CAD). The team consists of cardiologists, geneticists, and bioinformaticians who have extensive experience in the biotechnology and genomic industries. CardioDx is a privately held company funded by Kleiner, Perkins, Caufield & Byers, TPG Ventures, and Mohr Davidow Ventures.
more
Founded in 2004, CardioDx is a molecular diagnostics company located in Palo Alto, California. The company is developing clinically validated molecular diagnostics specifically for heart disease. These tests will help cardiologists identify patients who will benefit most from advanced cardiovascular therapies and predict risk for developing disease.
The company is focused in the areas of Congestive Heart Failure (CHF) and Coronary Artery Disease (CAD). The team consists of cardiologists, geneticists, and bioinformaticians who have extensive experience in the biotechnology and genomic industries. CardioDx is a privately held company funded by Kleiner, Perkins, Caufield & Byers, TPG Ventures, and Mohr Davidow Ventures.
